Ftse Mib
33.960,60
-1,28%
DAX
20.044,41
-1,07%
S&P 500
5.872,16
-2,95%
NASDAQ
19.392,69
0,00%
Bitcoin
101.969,64
1,91%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Standard BioTools Inc (LAB) Standard BioTools Inc (LAB) Notizie

Standard BioTools Inc

LAB
1,985
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
22/11/202402:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202421:32EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:13EDGAR2Form 144 - Report of proposed sale of securities
07/11/202414:06EDGAR2Form 8-K - Current report
07/11/202414:00GLOBEStandard BioTools Appoints Alex Kim as Chief Financial..
06/11/202423:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202413:01GLOBEStandard BioTools to Participate in Upcoming Investor..
30/10/202421:17EDGAR2Form 8-K - Current report
30/10/202421:01GLOBEStandard BioTools Reports Third Quarter 2024 Financial..
24/10/202420:02EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
21/10/202422:26EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
16/10/202414:00GLOBEStandard BioTools Announces Conference Call and Webcast for..
24/9/202414:00GLOBEStandard BioTools Achieves New Record of the Most Protein..
18/9/202414:00GLOBEStandard BioTools proteomics profiling reveals unique..
09/9/202421:19EDGAR2Form 144 - Report of proposed sale of securities
06/9/202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202422:07EDGAR2Form 8-K - Current report
03/9/202423:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/8/202422:08EDGAR2Form 8-K - Current report
30/8/202402:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202402:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202414:00GLOBEStandard BioTools to Present at the Morgan Stanley 22nd..
22/8/202402:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202401:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202402:54EDGAR2Form SC 13D/A - General Statement of Acquisition of..
14/8/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202403:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202403:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:39EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:01GLOBEStandard BioTools to Participate in Upcoming Investor..
31/7/202422:20EDGAR2Form 8-K - Current report
31/7/202422:12EDGAR2Form 8-K - Current report
31/7/202422:02GLOBEStandard BioTools Announces Senior Leadership Changes
31/7/202422:01GLOBEStandard BioTools Reports Second Quarter 2024 Financial..
24/7/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202414:01GLOBEStandard BioTools Announces Conference Call and Webcast for..
03/6/202423:20EDGAR2Form SC 13D/A - General statement of acquisition of..
03/6/202423:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
03/6/202412:05EDGAR2Form 8-K - Current report
29/5/202422:34EDGAR2Form SD - Specialized disclosure report
29/5/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:01GLOBEStandard BioTools Purchases the Carterra® LSA-XT System to..
23/5/202401:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:54EDGAR2Form SC 13D/A - General statement of acquisition of..
22/5/202422:01GLOBEStandard BioTools to Participate in Upcoming Investor..
21/5/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 1,985

La tua Cronologia

NASDAQ
LAB
Standard BioTools
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network